Information about CellCarta Biosciences
My details
*
*
*
{{translate('company_activity_bron_' + bron)}}
NACE Description
{{activiteit.code}} {{activiteit.description}}

CellCarta Biosciences (SA)

Company information
Status
Active
Enterprise number
BE0661.567.021
VAT liability
Yes
Established
18-08-2016
Last balance sheet year
2022
Company size
Big 48,2 FTE
Commercial name
CellCarta
Principal activity
Research and experimental development on biotechnology
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from CellCarta Biosciences

{{translate("download")}}

Publications in the Belgian Official Journal from CellCarta Biosciences

Date Publication
06-12-2024 Resignations, Appointments (FR)
04-12-2023 Resignations, Appointments (FR)
16-12-2021 Resignations, Appointments (FR)
03-05-2021 Articles of Association (Translation, Coordination, Other Modifications, …) - Denomination (FR)
05-01-2021 Resignations, Appointments (FR)

Frequently asked questions

What is the VAT number of CellCarta Biosciences?
The VAT number of CellCarta Biosciences is BE0661567021.
When was CellCarta Biosciences founded?
CellCarta Biosciences was founded on 18-08-2016.
What is the address of CellCarta Biosciences?
The current registered office of CellCarta Biosciences is located at Rue Adrienne Bolland 8/2, 6041 Charleroi.
When was the last time CellCarta Biosciences filed their annual financial statements?
The most recent financial statements of CellCarta Biosciences were filed on 13-02-2025. You can view them here.
How many employees does CellCarta Biosciences have?
There are 48,2 FTEs working at CellCarta Biosciences according to the staff figures in the most recent financial statements.
What is the annual turnover of CellCarta Biosciences?
At the time of its most recent financial statements, CellCarta Biosciences did not publish any turnover figures. CellCarta Biosciences reported a gross margin of €6,020,149.50.